{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:35:31Z","timestamp":1771655731499,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cyto.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T12:01:47Z","timestamp":1458216107000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The effect of interleukins 27 and 35 and their role on mediating the action of insulin Like Growth Factor -1 on the inflammation and blood flow of chronically inflamed rat knee joint"],"prefix":"10.1016","volume":"81","author":[{"given":"Nasrin","family":"Houshmandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-8704","authenticated-orcid":false,"given":"Hamid","family":"Najafipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyavash","family":"Joukar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahriar","family":"Dabiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Abbasloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Safi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.03.010_b0005","series-title":"Kelley\u2019s Textbook of Rheumatology: Expert Consult Premium Edition: Enhanced Online Features","author":"Firestein","year":"2012"},{"key":"10.1016\/j.cyto.2016.03.010_b0010","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2016.03.010_b0015","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1189\/jlb.0404248","article-title":"Insulin-like growth factor-I stimulates IL-10 production in human T cells","volume":"76","author":"Kooijman","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2016.03.010_b0020","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar1887","article-title":"The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis","volume":"8","author":"Fishman","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2016.03.010_b0025","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/hc1002.105187","article-title":"Tumor necrosis factor-\u03b1 regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle","volume":"105","author":"Anwar","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2016.03.010_b0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00296-010-1683-z","article-title":"Insulin-like growth factor I receptor density on CD4+ T-lymphocytes from active early steroid-and DMARD-na\u00efve rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment","volume":"32","author":"Laurberg","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cyto.2016.03.010_b0035","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.03.010_b0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-065X.2008.00710.x","article-title":"Regulation of immune responses by interleukin-27","volume":"226","author":"Yoshida","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2016.03.010_b0045","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.biocel.2008.05.020","article-title":"Interleukin 27 signaling pathways in regulation of immune and autoimmune responses","volume":"40","author":"Yoshida","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cyto.2016.03.010_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2008.01.011","article-title":"Advances in understanding the anti-inflammatory properties of IL-27","volume":"117","author":"Stumhofer","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2016.03.010_b0055","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.180.2.922","article-title":"IL-27 induces a Th1 immune response and susceptibility to experimental arthritis","volume":"180","author":"Cao","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.03.010_b0060","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/art.30322","article-title":"Interleukin-27: A master regulator in inflammation","volume":"63","author":"Fearon","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.03.010_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cyto.2015.01.019","article-title":"Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.03.010_b0070","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2016.03.010_b0075","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","article-title":"IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10","volume":"184","author":"Kochetkova","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.03.010_b0080","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/CVI.00052-11","article-title":"Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and-infected mice","volume":"18","author":"Kuo","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cyto.2016.03.010_b0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cyto.2014.05.015","article-title":"Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice","volume":"69","author":"Thiolat","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.03.010_b0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1113\/expphysiol.1995.sp003841","article-title":"Comparison of synovial PO2 and sympathetic vasoconstrictor responses in normal and acutely inflamed rabbit knee joints","volume":"80","author":"Najafipour","year":"1995","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.cyto.2016.03.010_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1113\/jphysiol.1992.sp019104","article-title":"Changes in synovial PO2 and blood flow in the rabbit knee joint due to stimulation of the posterior articular nerve","volume":"449","author":"Ferrell","year":"1992","journal-title":"J. Physiol."},{"key":"10.1016\/j.cyto.2016.03.010_b0100","first-page":"E345","article-title":"IGF-I increases forearm blood flow without increasing forearm glucose uptake","volume":"275","author":"Pendergrass","year":"1998","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.cyto.2016.03.010_b0105","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-030144","article-title":"Acute effects of growth hormone on vascular function in human subjects","volume":"88","author":"Napoli","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2016.03.010_b0110","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI200317455","article-title":"Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization","volume":"111","author":"Kondo","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.03.010_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0714.1999.tb02037.x","article-title":"Clinical course of an antigen induced arthritis model in the rabbit temporomandibular joint","volume":"28","author":"Tominaga","year":"1999","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.cyto.2016.03.010_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.1993.tb13443.x","article-title":"Sympathetic innervation and alpha-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint","volume":"108","author":"Najafipour","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cyto.2016.03.010_b0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1113\/expphysiol.1993.sp003711","article-title":"Sympathetic innervation and beta-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint","volume":"78","author":"Najafipour","year":"1993","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.cyto.2016.03.010_b0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jor.20942","article-title":"Effect of exogenous IGF-1 on chondrocyte apoptosis in a rabbit intraarticular osteotomy model","volume":"28","author":"Higgins","year":"2010","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.cyto.2016.03.010_b0135","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.4049\/jimmunol.173.10.6465","article-title":"Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27","volume":"173","author":"Goldberg","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.03.010_b0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/ar1227","article-title":"Biology of recently discovered cytokines: discerning the pro-and anti-inflammatory properties of interleukin-27","volume":"6","author":"Villarino","year":"2004","journal-title":"Arthritritis Res. Ther."},{"key":"10.1016\/j.cyto.2016.03.010_b0145","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2007.083360","article-title":"Interleukin 27 attenuates collagen-induced arthritis","volume":"67","author":"Niedbala","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2016.03.010_b0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0904-2512.2001.10057.x","article-title":"Immunohistochemical study of interleukin-1\u03b2 and interleukin-1 receptor antagonist in an antigen-induced arthritis of the rabbit temporomandibular joint","volume":"31","author":"Habu","year":"2002","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.cyto.2016.03.010_b0155","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1177\/00220345950740121001","article-title":"Development and histologic characterization of an animal model of antigen-induced arthritis of the juvenile rabbit temporomandibular joint","volume":"74","author":"Kapila","year":"1995","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.cyto.2016.03.010_b0160","first-page":"29","article-title":"Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis","volume":"28","author":"Lemmey","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2016.03.010_b0165","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.20811","article-title":"Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: Evidence of a link between an increased myofibroblast-like phenotype and highinflammation synovitis","volume":"52","author":"Kasperkovitz","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.03.010_b0170","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/art.30527","article-title":"Resistin and insulin\/insulinlike growth factor signaling in rheumatoid arthritis","volume":"63","author":"Bostr\u00f6m","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.03.010_b0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0003-9861(03)00215-7","article-title":"Transport and binding of insulin-like growth factor I through articular cartilage","volume":"415","author":"Garcia","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cyto.2016.03.010_b0180","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1074\/jbc.275.8.5860","article-title":"The insulin-like growth factors (IGFs) I and II bind to articular cartilage via the IGF-binding proteins","volume":"275","author":"Bhakta","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2016.03.010_b0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s000110050288","article-title":"IGF\/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis","volume":"47","author":"Martel-Pelletier","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cyto.2016.03.010_b0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jcb.20652","article-title":"The control of chondrogenesis","volume":"97","author":"Goldring","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cyto.2016.03.010_b0195","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2012.03622.x","article-title":"Interleukin-27 suppresses osteoclastogenesis via induction of interferon-\u03b3","volume":"137","author":"Park","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2016.03.010_b0200","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1038\/emm.2013.89","article-title":"In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis","volume":"45","author":"Moon","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cyto.2016.03.010_b0205","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/art.30324","article-title":"Local expression of interleukin-27 ameliorates collagen-induced arthritis","volume":"63","author":"Pickens","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.03.010_b0210","series-title":"The role of IL-27 and IL-35 in inflammatory diseases","author":"Cai","year":"2008"},{"key":"10.1016\/j.cyto.2016.03.010_b0215","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4049\/jimmunol.173.2.1171","article-title":"Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28subunit of IL-27","volume":"173","author":"Goldberg","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2016.03.010_b0220","doi-asserted-by":"crossref","first-page":"e0132674","DOI":"10.1371\/journal.pone.0132674","article-title":"Interleukin 35 synovial fluid levels are associated with disease activity of rheumatoid arthritis","volume":"10","author":"\u0160enolt","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2016.03.010_b0225","first-page":"82","article-title":"Dual effects of insulin-like growth factor-1 on the constitutive and inducible nitric oxide (NO) synthase\u2013dependent formation of NO in vascular cells","volume":"99","author":"Schini-Kerth","year":"1999","journal-title":"J. Endocrinol. Invest."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T02:15:49Z","timestamp":1718417749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616300497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":45,"alternative-id":["S1043466616300497"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.03.010","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of interleukins 27 and 35 and their role on mediating the action of insulin Like Growth Factor -1 on the inflammation and blood flow of chronically inflamed rat knee joint","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}